Derma Sciences Company Profile (NASDAQ:DSCI)

About Derma Sciences

Derma Sciences logoDerma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: DSCI
  • CUSIP: 24982750
Key Metrics:
  • Previous Close: $4.96
  • 50 Day Moving Average: $4.76
  • 200 Day Moving Average: $3.89
  • 52-Week Range: $2.85 - $6.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 49.60
  • P/E Growth: 0.00
  • Market Cap: $140.39M
  • Outstanding Shares: 28,305,000
  • Beta: 0.99
Additional Links:
Companies Related to Derma Sciences:

Analyst Ratings

Consensus Ratings for Derma Sciences (NASDAQ:DSCI) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $7.75 (56.25% upside)

Analysts' Ratings History for Derma Sciences (NASDAQ:DSCI)
Show:
DateFirmActionRatingPrice TargetDetails
1/9/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
1/7/2016Canaccord GenuityDowngradeBuy -> Hold$4.00View Rating Details
12/3/2015Roth CapitalBoost Price TargetBuy$9.50 -> $16.00View Rating Details
11/16/2015Piper Jaffray Cos.Lower Price TargetNeutral$6.00 -> $4.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Derma Sciences (NASDAQ:DSCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.08)$0.08$22.40 million$22.20 millionViewListenView Earnings Details
5/11/2016Q116($0.13)($0.07)$20.60 million$20.20 millionViewListenView Earnings Details
3/16/2016Q415($0.39)($0.38)$20.21 million$20.30 millionViewListenView Earnings Details
11/9/2015Q315($0.43)($0.35)$22.31 million$22.20 millionViewListenView Earnings Details
8/10/2015Q215($0.43)($0.36)$21.66 million$22.60 millionViewListenView Earnings Details
5/11/2015Q115($0.46)($0.42)$19.89 million$19.50 millionViewListenView Earnings Details
3/12/2015Q414($0.45)($0.37)$22.90 million$22.90 millionViewListenView Earnings Details
11/10/2014Q314($0.43)($0.45)$21.90 million$20.20 millionViewN/AView Earnings Details
8/7/2014Q2($0.46)($0.34)ViewListenView Earnings Details
5/8/2014Q1($0.32)($0.46)$19.79 million$19.80 millionViewListenView Earnings Details
3/14/2014Q4($0.36)($0.31)$21.26 million$20.70 millionViewListenView Earnings Details
11/13/2013Q3($0.44)($0.29)$21.96 million$22.10 millionViewListenView Earnings Details
8/12/2013Q2 2013($0.45)($0.43)$19.95 million$18.10 millionViewListenView Earnings Details
5/16/2013Q1 2013($0.37)($0.38)$19.00 million$18.80 millionViewListenView Earnings Details
11/12/2012Q312($0.37)($0.24)$19.00 million$19.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Derma Sciences (NASDAQ:DSCI)
Current Year EPS Consensus Estimate: $-0.04 EPS
Next Year EPS Consensus Estimate: $0.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.04)($0.04)($0.04)
Q4 20161$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Derma Sciences (NASDAQ:DSCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2015Srini ConjeevaramDirectorBuy1,100$6.50$7,150.00View SEC Filing  
8/14/2015Samuel E NavarroDirectorBuy10,000$6.51$65,100.00View SEC Filing  
8/13/2015Bruce F WessonDirectorBuy10,000$6.58$65,800.00View SEC Filing  
8/13/2015Edward J QuiltyCEOBuy15,000$6.65$99,750.00View SEC Filing  
8/13/2015Robert C ColeInsiderBuy5,000$6.73$33,650.00View SEC Filing  
6/12/2015Brett HewlettDirectorSell12,000$7.17$86,040.00View SEC Filing  
12/15/2014Srini ConjeevaramDirectorSell12,500$8.49$106,125.00View SEC Filing  
12/4/2014C Richard StaffordDirectorSell6,075$8.59$52,184.25View SEC Filing  
11/25/2014C Richard StaffordDirectorSell1,775$8.26$14,661.50View SEC Filing  
11/18/2014C Richard StaffordDirectorSell3,250$8.59$27,917.50View SEC Filing  
11/17/2014C Richard StaffordDirectorSell1,800$8.50$15,300.00View SEC Filing  
11/14/2014C Richard StaffordDirectorSell5,073$8.48$43,019.04View SEC Filing  
9/16/2014Barry WolfensonInsiderBuy3,750$7.99$29,962.50View SEC Filing  
5/19/2014Barry WolfensonInsiderBuy11,250$8.79$98,887.50View SEC Filing  
5/16/2014Edward QuiltyCEOBuy10,000$8.70$87,000.00View SEC Filing  
1/10/2014Ra Capital Management, LlcInsiderSell300,000$11.83$3,549,000.00View SEC Filing  
9/3/2013C Richard StaffordDirectorSell15,000$14.06$210,900.00View SEC Filing  
9/3/2013John YetterCFOSell12,100$14.16$171,336.00View SEC Filing  
5/30/2013William C MartinMajor ShareholderSell95,568$13.68$1,307,370.24View SEC Filing  
4/29/2013Ra Capital Management, LlcMajor ShareholderBuy3,945$11.40$44,973.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Derma Sciences (NASDAQ:DSCI)
DateHeadline
finance.yahoo.com logoOthers Overlooked Derma Sciences (DSCI), Should You Buy It Now? (NASDAQ:DSCI)
finance.yahoo.com - August 30 at 12:16 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:DSCI)
biz.yahoo.com - August 27 at 8:53 AM
streetinsider.com logoDerma Sciences (DSCI) Launches New MEDIHONEY Hydrogel Sheet Dressings; HCPCS Codes Received (NASDAQ:DSCI)
www.streetinsider.com - August 26 at 4:01 PM
streetinsider.com logoDerma Sciences (DSCI) Says AMNIOEXCEL Will be Considered for Coverage by NGS - StreetInsider.com (NASDAQ:DSCI)
www.streetinsider.com - August 26 at 7:48 AM
zacks.com logoLabCorp's Takeover of Sequenom Wins Antitrust Clearance (NASDAQ:DSCI)
www.zacks.com - August 25 at 4:45 PM
businesswire.com logoDerma Sciences Receives Reimbursement Coding for New MEDIHONEY ® Hydrogel Dressings (NASDAQ:DSCI)
www.businesswire.com - August 25 at 4:45 PM
News IconDerma Sciences Receives Reimbursement Coding for New MEDIHONEY Hydrogel Dressings (NASDAQ:DSCI)
www.cbs58.com - August 25 at 9:39 AM
publicnow.com logoDerma Sciences Receives Reimbursement Coding for New MEDIHONEY® Hydrogel Dressings (NASDAQ:DSCI)
www.publicnow.com - August 25 at 9:39 AM
feeds.reuters.com logoBRIEF-Derma Sciences gets reimbursement coding for medihoney hydrogel dressings (NASDAQ:DSCI)
feeds.reuters.com - August 25 at 8:24 AM
thestreet.com logoDerma Sciences' AMNIOEXCEL® Now Eligible For Reimbursement By Medicare Administrative Contractor NGS (NASDAQ:DSCI)
www.thestreet.com - August 24 at 4:39 PM
publicnow.com logoDerma Sciences’ AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS (NASDAQ:DSCI)
www.publicnow.com - August 24 at 4:39 PM
finance.yahoo.com logoEdited Transcript of DSCI earnings conference call or presentation 9-Aug-16 3:00pm GMT (NASDAQ:DSCI)
finance.yahoo.com - August 18 at 4:44 PM
publicnow.com logoDerma Sciences Names Russell Olsen President of Advanced Wound Care (NASDAQ:DSCI)
www.publicnow.com - August 18 at 8:04 AM
finance.yahoo.com logoDERMA SCIENCES, INC. Financials (NASDAQ:DSCI)
finance.yahoo.com - August 17 at 4:51 PM
capitalcube.com logoETF’s with exposure to Derma Sciences, Inc. : August 17, 2016 (NASDAQ:DSCI)
www.capitalcube.com - August 17 at 4:51 PM
capitalcube.com logoDerma Sciences, Inc. :DSCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:DSCI)
www.capitalcube.com - August 15 at 4:51 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equ (NASDAQ:DSCI)
biz.yahoo.com - August 11 at 10:32 PM
twst.com logoDerma Sciences Inc.: Derma Sciences Reports 2016 Second Quarter Financial Results (NASDAQ:DSCI)
www.twst.com - August 9 at 3:21 PM
sg.finance.yahoo.com logoDerma Sciences posts 2Q profit (NASDAQ:DSCI)
sg.finance.yahoo.com - August 9 at 3:21 PM
biz.yahoo.com logoQ2 2016 Derma Sciences Inc Earnings Release - Before Market Open (NASDAQ:DSCI)
biz.yahoo.com - August 9 at 7:58 AM
finance.yahoo.com logoDerma Sciences Reports 2016 Second Quarter Financial Results (NASDAQ:DSCI)
finance.yahoo.com - August 9 at 7:58 AM
4-traders.com logoDERMA SCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) (NASDAQ:DSCI)
www.4-traders.com - August 8 at 10:03 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:DSCI)
biz.yahoo.com - August 8 at 10:03 PM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 5.44% on August 03 - Equities.com (NASDAQ:DSCI)
www.equities.com - August 5 at 9:58 PM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 5.44% on August 03 (NASDAQ:DSCI)
www.equities.com - August 4 at 10:27 PM
twst.com logoDerma Sciences Inc.: Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI)
www.twst.com - August 4 at 4:56 PM
twst.com logoDerma Sciences Inc.: Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI)
www.twst.com - August 4 at 4:56 PM
publicnow.com logoDerma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th (NASDAQ:DSCI)
www.publicnow.com - August 3 at 4:50 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal (NASDAQ:DSCI)
biz.yahoo.com - August 1 at 6:06 AM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 12.53% on July 28 - Equities.com (NASDAQ:DSCI)
www.equities.com - July 29 at 10:02 PM
bizjournals.com logo$77.8M deal: Princeton tissue regeneraton firm buys Tennessee company (NASDAQ:DSCI)
www.bizjournals.com - July 28 at 9:07 PM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 12.53% on July 28 (NASDAQ:DSCI)
www.equities.com - July 28 at 9:07 PM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 6.16% on July 27 - Equities.com (NASDAQ:DSCI)
www.equities.com - July 28 at 3:23 PM
streetinsider.com logoDerma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal - StreetInsider.com (NASDAQ:DSCI)
www.streetinsider.com - July 28 at 3:23 PM
streetinsider.com logoDerma Sciences (DSCI) to Acquire BioD in ~$77.8M Deal (NASDAQ:DSCI)
www.streetinsider.com - July 28 at 9:29 AM
feeds.reuters.com logoBRIEF-Derma Sciences to acquire BIOD (NASDAQ:DSCI)
feeds.reuters.com - July 28 at 8:28 AM
publicnow.com logoDerma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products (NASDAQ:DSCI)
www.publicnow.com - July 28 at 7:48 AM
finance.yahoo.com logo7:31 am Derma Sciences to acquire BioD for an immediate transaction value of $21.3 mln, expects immediate accretion; announces a 42.0 mln private placement at $4.17/share, plans to guide for FY16 in August (NASDAQ:DSCI)
finance.yahoo.com - July 28 at 7:31 AM
equities.com logoDerma Sciences Inc. (DSCI) Jumps 6.16% on July 27 (NASDAQ:DSCI)
www.equities.com - July 27 at 10:21 PM
streetinsider.com logoDerma Sciences (DSCI) Enters Agreement to Sell FAD Division in $12.2M Deal (NASDAQ:DSCI)
www.streetinsider.com - July 27 at 10:21 PM
streetinsider.com logoDerma Sciences (DSCI) Enters Agreement to Sell FAD Division in $12.2M Deal - StreetInsider.com (NASDAQ:DSCI)
www.streetinsider.com - July 27 at 4:47 PM
feeds.reuters.com logoBRIEF-Derma Sciences to sell First-Aid Products division for $12.2 million (NASDAQ:DSCI)
feeds.reuters.com - July 27 at 9:09 AM
publicnow.com logoDerma Sciences to Sell First Aid Products Division for Approximately $12.2 Million (NASDAQ:DSCI)
www.publicnow.com - July 27 at 7:38 AM
News IconDerma Sciences, Inc. (NASDAQ:DSCI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:DSCI)
www.engelwooddaily.com - July 21 at 8:09 AM
capitalcube.com logoETF’s with exposure to Derma Sciences, Inc. : July 20, 2016 (NASDAQ:DSCI)
www.capitalcube.com - July 20 at 12:20 PM
equities.com logoDerma Sciences Inc. (DSCI) is Trading Higher on Unusual Volume for July 18 (NASDAQ:DSCI)
www.equities.com - July 20 at 8:44 AM
equities.com logoDerma Sciences Inc. (DSCI) is Trading Higher on Unusual Volume for July 18 - Equities.com (NASDAQ:DSCI)
www.equities.com - July 19 at 9:58 PM
News IconDerma Sciences, Inc. (NASDAQ:DSCI) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:DSCI)
telanaganapress.com - July 19 at 4:46 PM
News IconHow Many Derma Sciences Inc (NASDAQ:DSCI)'s Analysts Are Bearish? - Consumer Eagle (NASDAQ:DSCI)
www.consumereagle.com - July 17 at 9:15 AM
News IconShares Experiencing a Downtrend: Derma Sciences Inc. (NASDAQ:DSCI) - TGP (NASDAQ:DSCI)
telanaganapress.com - July 16 at 8:05 AM

Social

Derma Sciences (NASDAQ:DSCI) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff